Dr. Basmah Adel Abdalla, MD

Dr. Abdalla practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Abdalla's NPI, 1629394002, was assigned on April 11, 2010. Dr. Abdalla graduated from Ain Shams University Faculty of Medicine in 2008. Dr. Abdalla holds California license A135144.

Dr. Abdalla's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Abdalla's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Abdalla to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdalla practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Abdalla's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Abdalla is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Abdalla's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Abdalla treats.

CMS data shows 971 Medicare services from Dr. Abdalla across 6 procedure codes in 2024, for 271 Medicare patients. Medicare paid $90,445 for them.

CMS counts 271 Medicare patients who saw Dr. Abdalla in 2024. The largest group is under 65, with 167 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 62% are also on Medicaid. Their average risk score is 6.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdalla's median patient age at 55, with 38% women.

In 2024, Dr. Abdalla wrote 633 Medicare Part D claims for 185 patients. 91% of them were for generic drugs. CMS names the drug for 425 of them, across 13 drugs with 11 or more claims each, at $44,647 in total drug cost. In 2023, CMS named 549 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Abdalla for performance year 2024, reported as part of a group. Dr. Abdalla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdalla as offering telehealth.

CMS Open Payments shows 15 general payments to Dr. Abdalla from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 60% of the total. Mallinckrodt Enterprises LLC paid the most, $2,166.

Dr. Abdalla graduated from Ain Shams University Faculty of Medicine in 2008. Dr. Abdalla is a member of ACP and American Society of Transplantation.

Dr. Abdalla is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.